Table 2. Comparison of baseline characteristics between patients with elevated or normal hs-cTnT levels.
| Variable | Elevated hs-cTnT(n = 49) | Normal hs-cTnT(n = 3) | P | OR (95%CI) |
|---|---|---|---|---|
| Age, yr | 62.8(12.8) | 59.8(11.42) | 0.285 | |
| Female | 27(55.1%) | 26(74.3%) | 0.108 | 2.354(0.916–6.051) |
| Time to admission, h | 72.4(115.3) | 67.0(135.62) | 0.845 | |
| Risk factors | ||||
| Hypertension | 16(32.7%) | 4(11.4%) | 0.024* | 3.758(1.131–12.48) |
| Diabetes mellitus | 2(4.1%) | 0 | 0.226 | 1.043(0.984–1.105) |
| Hyperlipidemia | 2(4.1%) | 0 | 0.226 | 1.043(0.984–1.105) |
| Seizure | 3(6.1%) | 1(2.9%) | 0.488 | 2.217(0.221–22.25) |
| Coronary heart disease | 5(10.2%) | 1(2.9%) | 0.197 | 3.864(0.431–34.63) |
| Atrial fibrillation | 17(34.7%) | 8(22.9%) | 0.242 | 1.793(0.67–4.797) |
| eGFR<60 ml/min/1.73 m2 | 16(32.7%) | 4(11.4%) | 0.024* | 3.758(1.131–12.48) |
| Current smoking | 8(16.3%) | 5(14.3%) | 0.799 | 1.171(0.348–3.936) |
| Alcohol consumption | 3(6.1%) | 2(5.7%) | 0.938 | 1.076(0.17–6.804) |
| Previous MI history | 3(6.1%) | 0 | 0.136 | 1.065(0.992–1.144) |
| History of stroke | 5(10.2%) | 6(11.7%) | 0.353 | 0.549(0.153–1.968) |
| Stroke severity on admission | ||||
| NIHSS score, median | 12.0(8.0) | 10.1(7.0) | 0.255 | |
| PT on admission, sec | 13.2(3.9) | 10.1(7.0) | 0.265 | |
| APTT on admission, sec | 27.0(6.10) | 25.8(6.90) | 0.410 | |
| INR on admission | 1.21(0.37) | 1.11(0.25) | 0.157 | |
| Antiplatelet therapy | 42(85.7) | 32(91.4) | 0.511 | 0.563(0.135–2.347) |
| Anticoagulation therapy | 10(20.4) | 11(31.4) | 0.310 | 0.559(0.207–1.515) |
| Thrombolysis therapy | 2(4.1) | 2(5.7) | 0.729 | 0.702(0.094–5.240) |
Values are n (%) or mean ± SD.
Abbreviations: APTT, activated partial thromboplastin time; eGFR, estimated glomerular filtration rate; INR, international standard ratio; PT, prothrombin time; MI, myocardial infarction.